Page last updated: 2024-08-17

carbostyril and Weight Loss

carbostyril has been researched along with Weight Loss in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's7 (58.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnoldy, R; Curtis, J; Samaras, K1
Aida, SA; Hatim, A; Mohamed, Z; Reynolds, GP; Roffeei, SN; Said, MA; Zainal, NZ1
Anamthathmakula, P; Sahu, A; Sahu, M1
Kozumplik, O; Sedić, B; Uzun, S1
Basu, R; Brar, JS; Chang, CC; Ganguli, R; Garbut, R1
Bobo, WV; Chen, Y; Jayathilake, K; Meltzer, HY; Tang, T; Watts, K1
Azorin, JM; Gasquet, I; Gierski, F; Leguay, D; Lemogne, C; Limosin, F; Raucher-Chéné, D; Rouillon, F; Schuster, JP1
Harms, E; Kropp, S; Luebbe, G; Ziegenbein, M1
Lamberti, JS; Olsen, D; Spurling, RD; Tang, W; Tu, X1
Loebel, A; Siu, C; Warrington, L; Yang, R; Zimbroff, D1
Englisch, S; Zink, M1
Akune, A; Asaoka, H; Chihaya, Y; Ihara, T; Nagata, R; Nakama, K; Shindo, Y; Sumi, N1

Reviews

1 review(s) available for carbostyril and Weight Loss

ArticleYear
Combined antipsychotic treatment involving clozapine and aripiprazole.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Aug-01, Volume: 32, Issue:6

    Topics: Antipsychotic Agents; Aripiprazole; Clozapine; Drug Therapy, Combination; Humans; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Weight Loss

2008

Trials

4 trial(s) available for carbostyril and Weight Loss

ArticleYear
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.
    Human psychopharmacology, 2014, Volume: 29, Issue:1

    Topics: Adult; Alleles; Antipsychotic Agents; Aripiprazole; Body Mass Index; Female; Follow-Up Studies; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Piperazines; Polymorphism, Genetic; Quinolones; Receptors, Adrenergic, alpha-2; Schizophrenia; Thiazoles; Weight Gain; Weight Loss

2014
Changes in weight and other metabolic indicators in persons with schizophrenia following a switch to aripiprazole.
    Clinical schizophrenia & related psychoses, 2011, Volume: 5, Issue:2

    Topics: Antipsychotic Agents; Aripiprazole; Cardiovascular Diseases; Drug Substitution; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Overweight; Piperazines; Quinolones; Schizophrenia; Weight Loss

2011
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
    Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:9

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Atherosclerosis; Bipolar Disorder; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Dyslipidemias; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; North America; Patient Dropouts; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Schizophrenia; Severity of Illness Index; Thiazoles; Weight Loss

2012
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
    International clinical psychopharmacology, 2007, Volume: 22, Issue:6

    Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Aripiprazole; Blood Glucose; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Electrocardiography; Fasting; Humans; Lipids; Nausea; Piperazines; Prolactin; Quinolones; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Weight Loss

2007

Other Studies

7 other study(ies) available for carbostyril and Weight Loss

ArticleYear
The effects of antipsychotic switching on diabetes in chronic schizophrenia.
    Diabetic medicine : a journal of the British Diabetic Association, 2014, Volume: 31, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Blood Glucose; Clozapine; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Piperazines; Quinolones; Schizophrenia; Treatment Outcome; Weight Loss

2014
Hypothalamic Phosphodiesterase 3B Pathway Mediates Anorectic and Body Weight-Reducing Effects of Insulin in Male Mice.
    Neuroendocrinology, 2017, Volume: 104, Issue:2

    Topics: Animals; Body Weight; Cyclic Nucleotide Phosphodiesterases, Type 3; Eating; Gene Expression; Hypothalamus; Insulin; Leptin; Male; Mice; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Phosphorylation; Pro-Opiomelanocortin; Proto-Oncogene Proteins c-akt; Quinolones; Signal Transduction; STAT3 Transcription Factor; Weight Loss

2017
Changes in values of cholesterol and tryglicerides after weight loss during treatment with aripiprazole in a patient with schizophrenia - Case report.
    Psychiatria Danubina, 2010, Volume: 22, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Cholesterol; Croatia; Dose-Response Relationship, Drug; Feeding Behavior; Humans; Life Style; Male; Metabolic Syndrome; Piperazines; Quinolones; Schizophrenia; Triglycerides; Weight Loss

2010
Impact of switching or initiating antipsychotic treatment on body weight during a 6-month follow-up in a cohort of patients with schizophrenia.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:5

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Clozapine; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Quinolones; Risperidone; Schizophrenia; Weight Loss

2012
Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report.
    Pharmacopsychiatry, 2006, Volume: 39, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Piperazines; Quinolones; Schizophrenia; Weight Loss

2006
Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review.
    The Journal of clinical psychiatry, 2007, Volume: 68, Issue:3

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Male; Middle Aged; Outpatients; Piperazines; Quinolones; Retrospective Studies; Schizophrenia; Weight Loss

2007
[Single and 4-week oral toxicity studies of prulifloxacin (NM441) in aged dogs].
    The Journal of toxicological sciences, 1996, Volume: 21 Suppl 1

    Topics: Administration, Oral; Age Factors; Alanine Transaminase; Animals; Anti-Infective Agents; Aspartate Aminotransferases; Blood Urea Nitrogen; Creatinine; Dioxolanes; Dogs; Drinking; Eating; Female; Fluoroquinolones; Leukocyte Count; Male; Nephritis, Interstitial; Piperazines; Quinolones; Vomiting; Weight Loss

1996